Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1720893

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1720893

Sepsis Global Market Report 2025

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Sepsis is a life-threatening condition resulting from the body's extreme response to an infection. It occurs when the immune system releases chemicals into the bloodstream to combat the infection, but these chemicals trigger widespread inflammation, leading to tissue damage, organ failure, and potentially death.

The primary aspects of sepsis management include diagnosis and therapeutics. Diagnosis focuses on detecting sepsis through various tests and procedures that identify infections and assess their severity. The condition can be caused by pathogens such as bacteria, viruses, and fungi. Sepsis-related applications include severe sepsis and septic shock, with utilization in hospitals, pathology labs, and reference laboratories.

The sepsis market research report is one of a series of new reports from The Business Research Company that provides sepsis market statistics, including the sepsis industry's global market size, regional shares, competitors with a sepsis market share, detailed sepsis market segments, market trends and opportunities, and any further data you may need to thrive in the sepsis industry. This sepsis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the increasing incidence of sepsis due to aging populations, the rising prevalence of chronic diseases, greater awareness of sepsis among healthcare providers, escalating healthcare expenditures, and the implementation of government initiatives for early detection and management.

The sepsis market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the increasing adoption of artificial intelligence in critical care, the rising prevalence of multidrug-resistant infections, growing awareness campaigns about sepsis, expanding healthcare infrastructure in emerging economies, and increasing investments in biotechnology and pharmaceutical research. Major trends in the forecast period include the development of rapid point-of-care diagnostics, the adoption of AI-driven predictive analytics, personalized antibiotic stewardship programs, advancements in blood culture techniques, innovative biomarker identification, and the development of novel therapies targeting immune modulation.

The growing prevalence of infectious diseases is expected to drive the expansion of the sepsis market in the coming years. Infectious diseases, caused by bacteria, viruses, fungi, or parasites, can spread through direct contact, contaminated sources, or insect vectors. Common examples include tuberculosis, influenza, ringworm, and malaria. Several factors contribute to the increasing incidence of infectious diseases, including globalization, environmental changes, drug-resistant pathogens, and gaps in healthcare systems. Sepsis, a severe complication of infections, results from the body's extreme response, leading to widespread inflammation and potential organ failure. For example, in November 2024, the Centers for Disease Control and Prevention reported that the United States recorded 9,633 cases of tuberculosis (TB) in 2023, marking a 15.6% increase from the 8,332 cases reported in 2022. Consequently, the rising burden of infectious diseases is fueling the growth of the sepsis market.

Companies in the sepsis market are leveraging advanced technology, such as artificial intelligence (AI)-powered platforms, to improve early diagnosis, enhance treatment precision, and predict patient outcomes. These innovations aim to reduce mortality rates and enhance healthcare efficiency in managing sepsis. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched OpenDX, an AI-powered diagnostic platform integrating wearable biosensors to detect early signs of sepsis. This technology aids in sepsis diagnosis and has the potential for application in other medical conditions, highlighting the increasing role of AI in diagnostics. Predicate's chest sensor enables healthcare professionals to identify early indicators of sepsis, a condition that is often challenging to diagnose.

In April 2024, Prenosis Inc., a US-based biotechnology research company, partnered with Roche Holding AG to advance sepsis diagnosis and management through AI-driven technology. As part of the partnership, Roche will distribute Prenosis' Sepsis ImmunoScore, an AI-based medical software designed to assist healthcare providers in rapidly diagnosing sepsis and predicting adverse outcomes. This collaboration enhances clinical sepsis management by integrating AI technology into healthcare settings. Roche Holding AG is a Switzerland-based pharmaceutical company specializing in oncology, immunology, infectious diseases, and other medical fields.

Major players in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMerieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.

North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis market includes revenues earned by entities by providing services such as blood culture testing, molecular diagnostics, biomarker testing, intravenous (IV) fluid management, organ support services, and tele-ICU services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Diagnosis; Therapeutics
  • 2) By Pathogen: Bacterial; Viral; Fungal
  • 3) By Application: Severe Sepsis; Septic Shock
  • 4) By End User: Hospitals; Pathology; Reference Laboratories
  • Subsegments:
  • 1) By Diagnosis: Blood Tests; Imaging Techniques; Microbiological Culture Tests; Biomarker Tests; Other Diagnostic Methods
  • 2) By Therapeutics: Antibiotics; Antifungal Agents; Vasopressors; Immunoglobulins; Corticosteroids; Other Therapeutic Options
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck KGaA; Bayer AG; Thermo Fisher Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r34152

Table of Contents

1. Executive Summary

2. Sepsis Market Characteristics

3. Sepsis Market Trends And Strategies

4. Sepsis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Sepsis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sepsis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sepsis Market Growth Rate Analysis
  • 5.4. Global Sepsis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sepsis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sepsis Total Addressable Market (TAM)

6. Sepsis Market Segmentation

  • 6.1. Global Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnosis
  • Therapeutics
  • 6.2. Global Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial
  • Viral
  • Fungal
  • 6.3. Global Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Severe Sepsis
  • Septic Shock
  • 6.4. Global Sepsis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Pathology
  • Reference Laboratories
  • 6.5. Global Sepsis Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Imaging Techniques
  • Microbiological Culture Tests
  • Biomarker Tests
  • Other Diagnostic Methods
  • 6.6. Global Sepsis Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibiotics
  • Antifungal Agents
  • Vasopressors
  • Immunoglobulins
  • Corticosteroids
  • Other Therapeutic Options

7. Sepsis Market Regional And Country Analysis

  • 7.1. Global Sepsis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sepsis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sepsis Market

  • 8.1. Asia-Pacific Sepsis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sepsis Market

  • 9.1. China Sepsis Market Overview
  • 9.2. China Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sepsis Market

  • 10.1. India Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sepsis Market

  • 11.1. Japan Sepsis Market Overview
  • 11.2. Japan Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sepsis Market

  • 12.1. Australia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sepsis Market

  • 13.1. Indonesia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sepsis Market

  • 14.1. South Korea Sepsis Market Overview
  • 14.2. South Korea Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sepsis Market

  • 15.1. Western Europe Sepsis Market Overview
  • 15.2. Western Europe Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sepsis Market

  • 16.1. UK Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sepsis Market

  • 17.1. Germany Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sepsis Market

  • 18.1. France Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sepsis Market

  • 19.1. Italy Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sepsis Market

  • 20.1. Spain Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sepsis Market

  • 21.1. Eastern Europe Sepsis Market Overview
  • 21.2. Eastern Europe Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sepsis Market

  • 22.1. Russia Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sepsis Market

  • 23.1. North America Sepsis Market Overview
  • 23.2. North America Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sepsis Market

  • 24.1. USA Sepsis Market Overview
  • 24.2. USA Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sepsis Market

  • 25.1. Canada Sepsis Market Overview
  • 25.2. Canada Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sepsis Market

  • 26.1. South America Sepsis Market Overview
  • 26.2. South America Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sepsis Market

  • 27.1. Brazil Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sepsis Market

  • 28.1. Middle East Sepsis Market Overview
  • 28.2. Middle East Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sepsis Market

  • 29.1. Africa Sepsis Market Overview
  • 29.2. Africa Sepsis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sepsis Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sepsis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sepsis Market Competitive Landscape And Company Profiles

  • 30.1. Sepsis Market Competitive Landscape
  • 30.2. Sepsis Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sepsis Market Other Major And Innovative Companies

  • 31.1. Abbott laboratories
  • 31.2. Novartis AG
  • 31.3. Siemens AG
  • 31.4. Asahi Kasei Corporation
  • 31.5. Becton, Dickinson and Company
  • 31.6. bioMerieux SA
  • 31.7. QuidelOrtho Corporation
  • 31.8. Diasorin S.p.A.
  • 31.9. Innoviva Inc.
  • 31.10. Seegene Inc.
  • 31.11. EKF Diagnostics
  • 31.12. Boditech Med Inc.
  • 31.13. Cytovale Inc.
  • 31.14. Alifax S.r.l.
  • 31.15. Hansa Biopharma

32. Global Sepsis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sepsis Market

34. Recent Developments In The Sepsis Market

35. Sepsis Market High Potential Countries, Segments and Strategies

  • 35.1 Sepsis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sepsis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sepsis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!